Skip to content
BALCAO · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS · SMALL CAP

Target Group Inc. CBDY

12 fiscal years on record · USD · FY2025 reported · SEC filings only
$3.9M
▼ 41.1% YoY
$-1.4M
▼ 947.1% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

Effective July 1, 2025, the Company’s common stock is quoted on the Pink Limited Market operated by OTC Markets Group Inc, under the symbol “CBDY”. The Company is engaged in the cultivation, processing and distribution of curated cannabis products for the medical and adult-use recreational cannabis market in Canada and continues to evaluate opportunities, where legalized by state legislation or related to rescheduling, in the United States. As of the date of this report, the Company and its subsidiaries do not have any operations, employees or corporate offices based in United States. Visava owns 100% of Canary Rx Inc, a Canadian corporation (“Canary”) that operates a 44,000 square foot facility located in Ontario’s Garden Norfolk County for the production of cannabis.

Written from the business description in Target Group Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 31 March 2026. Every sentence was checked against that document before publication.

Growth

USD 3.9M
Revenue, FY2025 · full 12-year series below
Revenue $M Net income $M
FY2025 · Revenue 3.9 · Net income -1.4
2.5M5.0M-5.0M-10.0M
20142017202020232025
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−35 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -35.0% · Net -35.0%
-200000%-400000%-600000%
201420192025
ROE

Not applicable: equity was zero or negative in this period, so return on equity has no meaning.

Three returns, three denominators.
Return on equityNot applicable: equity was zero or negative in this period, so return on equity has no meaning.
Return on capital employedNot applicable: capital employed was zero or negative in this period, so return on capital employed has no meaning.
Gross margin53.3%
Operating margin-35.0%
Net margin-35.0%
EBITDAUSD -461,279.00

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2020 · FCF -1.5
-4M-8M
201420192025
Net buybacks $ Dividends $
FY2015 · Dividends · · Net buybacks -12500.0
-5000-10000
20142015

Total assetsUSD 6.2M
EquityUSD -8.1M
CashUSD 108,800.00
Gross debtUSD 15.2M
Net debtUSD 15.1M
Current ratio0.17×

Equity was zero or negative — liabilities equaled or exceeded assets. No ratio is shown.

The 12-year record

12 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
CBDY, 12-year financial record
Metric 202520242023202220212020201920182017201620152014
Revenue $B0.00.00.00.00.00.00.00.00.00.00.0◌
Operating income $B−0.00.0−0.0−0.00.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EBITDA $B−0.00.00.0−0.00.0−0.0−0.0−0.0◌◌◌◌
Income tax $B0.00.00.00.00.00.00.00.00.00.00.00.0
Net income $B−0.00.0−0.0−0.00.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Free cash flow $B◌◌◌◌◌−0.0−0.0◌◌◌◌◌
EPS, diluted $−0.000.00−0.00−0.010.00−0.01−0.03−0.04−0.72−85.83−0.34−0.03
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend————————————
ROE %——————−290.7—————
Shares out B0.620.620.620.620.620.570.570.090.010.000.020.01

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 54 reconciliationsAUDITED

Reconciled in 12 of the 12 fiscal years we could check. 14 checks were skipped: the balance sheet is not tagged before 2014. 12 checks were skipped: cost of revenue is not tagged before 2019. Seven checks were skipped: EPS is not tagged before 2014.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityMedicinal Chemicals & Botanical Products
Listed onOTC market
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2014

Share this section

Download image